Sponsor Pipeline

Riboscience, LLC. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07175441 Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants… Advanced Unresectable Hepatocellular Carcinoma Recruiting
NCT06824064 Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal… Metastatic Colorectal Cancer Recruiting
Phase 1
NCT05270213 Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors Advanced Cancer Recruiting
Disease Areas
Get alerts when Riboscience, LLC.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free